SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Giovannucci Edward)
 

Sökning: WFRF:(Giovannucci Edward) > (2015-2019) > Midlife metabolic f...

Midlife metabolic factors and prostate cancer risk in later life

Dickerman, Barbra A. (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA
Torfadottir, Johanna E. (författare)
Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland
Valdimarsdottir, Unnur A. (författare)
Karolinska Institutet
visa fler...
Wilson, Kathryn M. (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA; Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Steingrimsdottir, Laufey (författare)
Unit for Nutrition Research, University Hospital, Reykjavik, Iceland; Faculty of Food Science and Nutrition, University of Iceland, Reykjavik, Iceland
Aspelund, Thor (författare)
Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland; The Icelandic Heart Association, Kopavogur, Iceland
Batista, Julie L. (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA;
Fall, Katja, 1971- (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA,Clinical Epidemiology and Biostatistics
Giovannucci, Edward (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston MA, USA
Sigurdardottir, Lara G. (författare)
Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Education and Prevention, The Icelandic Cancer Society, Reykjavik, Iceland
Tryggvadottir, Laufey (författare)
The Icelandic Cancer Registry, Reykjavik, Iceland
Gudnason, Vilmundur (författare)
The Icelandic Heart Association, Kopavogur, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland
Markt, Sarah C. (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA
Mucci, Lorelei A. (författare)
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA, USA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston MA, USA
visa färre...
Department of Epidemiology, Harvard TH. Chan School of Public Health, Boston MA, USA Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland (creator_code:org_t)
2017-11-16
2018
Engelska.
Ingår i: International Journal of Cancer. - Hoboken, USA : John Wiley & Sons. - 0020-7136 .- 1097-0215. ; 142:6, s. 1166-1173
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Metabolic syndrome is associated with several cancers, but evidence for aggressive prostate cancer is sparse. We prospectively investigated the influence of metabolic syndrome and its components on risk of total prostate cancer and measures of aggressive disease in a cohort of Icelandic men. Men in the Reykjavik Study (n = 9,097, enrolled 1967-1987) were followed for incident (n = 1,084 total; n = 378 advanced; n = 148 high-grade) and fatal (n = 340) prostate cancer until 2014. Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for (1) measured metabolic factors at cohort entry (body mass index (BMI), blood pressure, triglycerides, fasting blood glucose) and (2) a metabolic syndrome score (range 0-4) combining the risk factors: BMI ≥30 kg/m2 ; systolic blood pressure (SBP) ≥130 or diastolic blood pressure (DBP) ≥85 mm Hg or taking antihypertensives; triglycerides ≥150 mg/dl; fasting blood glucose ≥100 mg/dl or self-reported type 2 diabetes. Hypertension and type 2 diabetes were associated with a higher risk of total, advanced, high-grade, and fatal prostate cancer, independent of BMI. Neither BMI nor triglycerides were associated with prostate cancer risk. Higher metabolic syndrome score (3-4 vs 0) was associated with a higher risk of fatal prostate cancer (HR 1.55; 95% CI: 0.89, 2.69; p trend = 0.08), although this finding was not statistically significant. Our findings suggest a positive association between midlife hypertension and diabetes and risk of total and aggressive prostate cancer. Further, metabolic syndrome as a combination of factors was associated with an increased risk of fatal prostate cancer.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Prostate cancer
metabolic syndrome
BMI
hypertension
triglycerides
fasting blood glucose
diabetes

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy